Drugs Made in America Ac-RTSDMAARPreferred / convertible

13F holders, Q3 2025 (September 30)
32holders +8
11new positions
3sold out
$0.41avg. 13F price*

At the end of Q3 2025, 32 institutions reported holding Drugs Made in America Ac-RTS (DMAAR) in their 13F filings, up 8 from Q2 2025. 11 opened new positions and 3 sold out. The largest holders were Radcliffe Capital Management, L.P. ($3.3M), Polar Asset Management Partners Inc. ($413K) and Hudson Bay Capital Management LP ($391K).

Company
Drugs Made in America Ac-RTS
CUSIP
G2847J112
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q1 2025: 19Q1 2025Q2 2025: 24Q2 2025Q3 2025: 32Q3 2025Q4 2025: 32Q4 2025Q1 2026: 35Q1 2026Q2 2026: 28Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions11$3.9M
Exits3$187K

All 13F filers, Q2 2025 → Q3 2025: 3,115,824 shares bought and 3,923,214 shares sold, net −807,390 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 32 holders
Radcliffe Capital Management, L.P. — New 325,100 $3.3M
Polar Asset Management Partners Inc. — No change 1,900,000 $413K
Hudson Bay Capital Management LP — No change 1,800,000 $391K
Harraden Circle Investments, LLC — No change 1,500,000 $326K
Toronto Dominion Bank — Reduce -48.6% 1,000,000 $217K
Highbridge Capital Management LLC — Add +15.7% 983,600 $214K
Aristeia Capital, L.L.C. — Reduce -0.7% 881,716 $192K
Mangrove Partners Im, LLC — No change 850,000 $185K
Linden Advisors LP — New 850,000 $175K
Clear Street Group Inc. — — 659,093 $143K
Glazer Capital, LLC — Reduce -54.8% 588,300 $128K
Shaolin Capital Management LLC — New 575,000 $125K
Boothbay Fund Management, LLC — No change 570,000 $124K
Atw Spac Management LLC — No change 570,000 $124K
Wolverine Asset Management LLC — Reduce -6.3% 563,138 $122K
AQR Arbitrage LLC — No change 500,000 $109K
Westchester Capital Management, LLC — No change 500,000 $109K
LMR Partners LLP — No change 500,000 $109K
Whitebox Advisors LLC — No change 400,000 $87K
Alpine Global Management, LLC — New 362,500 $79K
Rivernorth Capital Management, LLC — New 317,998 $69K
Heights Capital Management, Inc. — Reduce -54.4% 289,302 $63K
CSS LLC — New 31,250 $54K
Context Capital Management, LLC — New 250,000 $54K
Schonfeld Strategic Advisors LLC — Reduce -64.5% 147,007 $32K
Bulldog Investors, LLP — Add +78.5% 130,264 $28K
Verition Fund Management LLC — No change 100,000 $22K
Quarry LP — Reduce -33.3% 100,000 $22K
Parallax Volatility Advisers, L.P. — New 87,926 $19K
Periscope Capital Inc. — New 75,000 $16K
Readystate Asset Management LP — New 50,000 $11K
UBS Group AG — New 150 $33

"% of holder's portfolio" is DMAAR's weight in each manager's 13F, not the share of Drugs Made in America Ac-RTS the manager owns.